Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASCT and Interferon-Alpha in Follicular Lymphoma
NCT00003152Phase 3Terminated
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Mar 1997
- Primary completion
- Nov 1999
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of cyclophosphamide in follicular lymphoma (FL), sponsored by European Organisation for Research and Treatment of Cancer. Started Mar 1997; status: terminated.
02
Drugs
cyclophosphamide
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00003152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003152.